Mr. Buckley, I do agree that obviously NHPs have a different risk profile from pharmaceuticals and drugs on the market. Within a two-year period, there were Health Canada reports of 1,000 adverse reactions from NHPs. It included 772 hospitalizations and adverse effects.
There is a balance. I agree there is a balance that needs to be struck with, again, making sure that Canadians have access to these products, but at the same time making sure that safety is absolutely paramount. One adverse reaction, or one negative impact, is one too many.